Ferlay J, Shin H R, Bray F,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12): 2893-2917. [2]Chen M F, Yang Y H, Lai C H,et al. Outcome of patients with esophageal cancer: a nationwide analysis[J]. Ann Surg Oncol, 2013, 20(9): 3023-3030. [3]Cheung W Y, Liu G. Genetic variations in esophageal cancer risk and prognosis[J]. Gastroenterol Clin North Am, 2009, 38(1): 75-91, viii. [4]Redon R, Ishikawa S, Fitch K R,et al. Global variation in copy number in the human genome[J]. Nature,2006, 444(7ll8): 444-454. [5]Stranger B E, Forrest M S, Dunning M,et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes[J]. Science, 2007, 315(5813): 848-853. [6]Fanciulli M, Petretto E, Aitman T J. Gene copy number variation and common human disease[J]. Clin Genet, 2010, 77(3): 201-213. [7]Kuiper R P, Ligtenberg M J, Hoogerbrugge N,et al Germline copy number variation and cancer risk[J]. Curr Opin Genet Dev, 2010, 20(3): 282-289. [8]Hou J, Jiang D, Zhang J,et al. Frequency, characterization, and prognostic analysis of PIK3CA gene mutations in Chinese esophageal squamous cell carcinoma[J]. Hum Pathol, 2014, 45(2): 352-358. [9]He M L, Wu Y, Zhao J M,et al. PIK3CA and AKT gene polymorphisms in susceptibility to osteosarcoma in a Chinese population[J]. Asian Pac J Cancer Prev, 2013, 14(9): 5117-5122. [10]Kuiper R P, Ligtenberg M J, Hoogerbrugge N,et al. Germline copy number variation and cancer risk[J]. Curr Opin Genet Dev, 2010, 20(3): 282-289. [11]Sun Y, Shi N, Lu H,et al. ABCC4 copy number variation is associated with susceptibility to esophageal squamous cell carcinoma[J]. Carcinogenesis, 2014, 35(9): 1941-1950. [12]Li B, Cheung P Y, Wang X,et al. Id-1 activation of PI3K/Akt/NFkappaB signaling pathway and its significance in promoting survival of esophageal cancer cells[J]. Carcinogenesis, 2007, 28(11): 2313-2320. [13]Agell L, Hernandez S, Salido M,et al. PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events[J]. Mod Pathol, 2011, 24(3): 443-452. [14]Henrichsen C N, Vinckenbosch N, Zollner S,et al. Segmental copy number variation shapes tissue transcriptomes[J]. Nat Genet, 2009, 41(4): 424-429. [15]Wang W F, Xie Y, Zhou Z H,et al. PIK3CA hypomethylation plays a key role in activation of the PI3K/AKT pathway in esophageal cancer in Chinese patients[J]. Acta Pharmacol Sin, 2013, 34(12): 1560-1567. ？
